A detailed history of Lifeworks Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lifeworks Advisors, LLC holds 33,698 shares of ABBV stock, worth $6.5 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
33,698
Previous 32,429 3.91%
Holding current value
$6.5 Million
Previous $5.56 Million 19.63%
% of portfolio
1.34%
Previous 1.58%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $207,912 - $252,949
1,269 Added 3.91%
33,698 $6.65 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $688,505 - $804,020
4,448 Added 15.9%
32,429 $5.56 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $362,471 - $413,002
2,268 Added 8.82%
27,981 $5.1 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $66,323 - $74,695
482 Added 1.91%
25,713 $3.98 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $125,574 - $145,371
940 Added 3.87%
25,231 $3.76 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $518,246 - $644,923
3,911 Added 19.19%
24,291 $3.27 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $46,998 - $54,125
-325 Reduced 1.57%
20,380 $3.25 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $13,416 - $16,089
97 Added 0.47%
20,705 $3.35 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $473,895 - $543,526
-3,531 Reduced 14.63%
20,608 $3.02 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $344,600 - $438,099
2,504 Added 11.57%
24,139 $3.7 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $843,352 - $1.05 Million
6,390 Added 41.92%
21,635 $3.51 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $1.64 Million - $2.07 Million
15,245 New
15,245 $2.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $341B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lifeworks Advisors, LLC Portfolio

Follow Lifeworks Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lifeworks Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lifeworks Advisors, LLC with notifications on news.